Mycobacterium vaccae as Adjuvant Therapy to Anti-Tuberculosis Chemotherapy in Never-Treated Tuberculosis Patients: A Meta-Analysis-Reference-Cited by-同舟云学术

Mycobacterium vaccae as Adjuvant Therapy to Anti-Tuberculosis Chemotherapy in Never-Treated Tuberculosis Patients: A Meta-Analysis

Published:2011-09-06 Issue:9 Volume:6 Page:e23826
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yang Xiao-Yan,Chen Qun-Fei,Li You-Ping,Wu Si-Miao

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference64 articles.

1. The characteristics of Th1/Th2 immune response of tuberculosis patient.;T Ren;International Journal of Medicine volumes,2003

2. Immunotherapy with Mycobacterium vaccae in the treatment of tuberculosis.;JL Stanford;Frontiers in Bioscience,2004

3. Mycobacterium vaccae in immunoprophylaxis and immunotherapy of leprosy and tuberculosis.;JL Stanford;Vaccine,1990

4. Adjuvant Effect of Mycobacterium vaccae on Treatment of Recurrent Treated Pulmonary Tuberculosis: A Meta-analysis.;MY Fan;Chinese Journal of evidence-based medicine,2007

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal;Heliyon;2024-02

2. Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention;MedComm;2024-01

3. Mechanisms of ag85a/b DNA vaccine conferred immunotherapy and recovery from Mycobacterium tuberculosis‐induced injury;Immunity, Inflammation and Disease;2023-05

4. Immune Approaches in Tuberculosis Treatment;Integrated Science;2023

5. A Credibility Assessment Plan for an In Silico Model that Predicts the Dose–Response Relationship of New Tuberculosis Treatments;Annals of Biomedical Engineering;2022-09-17